Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Keun-Wook Lee"'
Autor:
Hironaga Satake, Keun-Wook Lee, Hyun Cheol Chung, Jeeyun Lee, Kensei Yamaguchi, Jen-Shi Chen, Takaki Yoshikawa, Kenji Amagai, Kun-Huei Yeh, Masahiro Goto, Yee Chao, Ka-On Lam, Shi Rong Han, Shinichi Shiratori, Sukrut Shah, Kohei Shitara
Publikováno v:
Japanese Journal of Clinical Oncology. 53:221-229
ObjectiveFirst-line pembrolizumab with/without chemotherapy versus chemotherapy was evaluated in programmed death ligand 1 combined positive score ≥1, locally advanced/unresectable or metastatic gastric cancer/gastrooesophageal junction cancer in t
Autor:
Keun-Wook Lee, Jin Won Kim, Duck-Woo Kim, Heung Kwon Oh, Ji Won Kim, Jee Hyun Kim, Jae Sung Kim, Changhoon Song, Sung Bum Kang, Younak Choi
Publikováno v:
Japanese journal of clinical oncology. 46(12)
OBJECTIVE Preoperative chemoradiotherapy has been established as a standard treatment for locally advanced rectal cancer. It is unclear whether preoperative chemoradiotherapy is truly beneficial in the elderly patients. Our aim was to assess the impa
Autor:
Jong Seok Lee, Keun-Wook Lee, Soo Mee Bang, Yu Jung Kim, Seung Hoon Beom, Jin-Haeng Chung, Yaewon Yang, Jee Hyun Kim, Younak Choi, Kyoung Ho Song
Publikováno v:
Japanese Journal of Clinical Oncology. 41:1287-1291
We report the first case of adrenocortical carcinoma secreting cortisol (Cushing's syndrome) and aldosterone (Conn's syndrome) with extensive distant metastasis at the time of diagnosis. A 72-year-old male with exertional dyspnea sought evaluation at
Publikováno v:
Japanese Journal of Clinical Oncology. 41:430-433
When oncologists encounter patients with pulmonary pleomorphic carcinoma, most cases have recurrent disease after surgery or metastatic disease. Previous studies have suggested that patients with pleomorphic carcinoma have extremely poor responses to
Autor:
Seock-Ah Im, Tae-You Kim, Do-Youn Oh, Jee Hyun Kim, Joo Han Lim, Yung-Jue Bang, Hyeon Gyu Yi, Jong Seok Lee, Keun-Wook Lee, Myung Deok Seo, Dae-Young Kim
Publikováno v:
Japanese Journal of Clinical Oncology. 38:589-595
Objective: We analysed the efficacy and toxicity of irinotecan, leucovorin and 5-fluorouracil (FOLFIRI) chemotherapy as second-line treatment for metastatic or relapsed gastric cancer (MRGC) in a clinical practice setting. Factors to select patients
Autor:
Dae-Young Kim, Tae-You Kim, Yung-Jue Bang, Noe Kyeong Kim, Dong Wan Kim, Tak Yun, Keun Wook Lee, Dae Seog Heo, Jooyoung Jung, Sook Ryun Park
Publikováno v:
Japanese Journal of Clinical Oncology. 33:608-612
To compare the efficacy of intrathecal methotrexate single therapy with three-drug combination therapy in patients with leptomeningeal carcinomatosis.Fifty-five patients who had pathologically proven leptomeningeal carcinomatosis of a solid tumor wer
Autor:
Jee Hyun Kim, Keun-Wook Lee, Sung Bum Kang, Jong Seok Lee, Hye Seung Lee, Duck-Woo Kim, Jiyeon Kim, Na Young Jang, Jae Sung Kim, Yu Jung Kim
Publikováno v:
Japanese journal of clinical oncology. 43(2)
Objective: Elderly patients derive similar benefits from 5-fluorouracil-based adjuvant chemotherapy in Stage III colon cancer; however, conflicting data exist regarding additional benefit from oxaliplatin, fluorouracil and leucovorin (FOLFOX) chemoth
Autor:
Hee Eun Lee, Chung Jong Kim, Haeryoung Kim, Jee Hyun Kim, Keun-Wook Lee, Jong-Seok Lee, Jeong Ok Lee, Soo Mee Bang, Yu Jung Kim, Jae Sung Kim
Publikováno v:
Japanese journal of clinical oncology. 39(3)
Adrenocortical carcinoma (ACC) is a rare malignancy with poor prognosis. Palliative chemotherapy can be considered in patients with metastatic disease. Although mitotane- or cisplatin-based chemotherapy regimens are widely used, the effects of these
Autor:
Ho Il Yoon, Jee Hyun Kim, Keun-Wook Lee, Jong-Mu Sun, Jong Seok Lee, Choon-Taek Lee, Yu Jung Kim, Jae Ho Lee
Publikováno v:
Japanese journal of clinical oncology. 39(1)
Objective: Pemetrexed has been approved for second-line treatment in non-small cell lung cancer (NSCLC). However, the role of third-line pemetrexed therapy in NSCLC has not yet been generally accepted. We attempted to validate third-line pemetrexed t
Autor:
Eun Kee Song, Noe Kyeong Kim, Do Youn Oh, Seock-Ah Im, Hyunchoon Shin, Tae-You Kim, Dae Seog Heo, Dong Wan Kim, Yung-Jue Bang, Keun Wook Lee, Tak Yun, Jong-Seok Lee, Im Il Na, In Sil Choi, Jee Hyun Kim
Publikováno v:
Japanese journal of clinical oncology. 35(12)
Paclitaxel has shown promising activity in gastric cancer and has synergism with cisplatin. This study was performed to evaluate the efficacy and toxicity of low-dose paclitaxel (145 mg/m(2)) plus cisplatin chemotherapy in metastatic or relapsed gast